Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals

Lambotte, 2005, HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication, Clin Infect Dis, 41, 1053, 10.1086/433188 Lefrère, 1999, Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection, J Infect Dis, 180, 526, 10.1086/314906 Deeks, 2007, Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy, Immunity, 27, 406, 10.1016/j.immuni.2007.08.010 Gaardbo, 2013, Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors, PLoS ONE, 8, e63744, 10.1371/journal.pone.0063744 Migueles, 2008, Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control, Immunity, 29, 1009, 10.1016/j.immuni.2008.10.010 Hersperger, 2011, Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression, Blood, 117, 3799, 10.1182/blood-2010-12-322727 Betts, 2006, HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, 107, 4781, 10.1182/blood-2005-12-4818 Hersperger, 2010, Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control, PLoS Pathog, 6, e1000917, 10.1371/journal.ppat.1000917 Zanussi, 1996, CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection, Clin Exp Immunol, 105, 220, 10.1046/j.1365-2249.1996.d01-746.x Migueles, 2000, HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors, Proc Natl Acad Sci USA, 97, 2709, 10.1073/pnas.050567397 Haridas, 2003, Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents, AIDS, 17, 2313, 10.1097/00002030-200311070-00005 Betts, 2006, HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, 107, 4781, 10.1182/blood-2005-12-4818 Poonia, 2014, Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy, PLoS ONE, 10, e88884, 10.1371/journal.pone.0088884 Pollard, 2014, Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial, Lancet Infect Dis, 14, 291, 10.1016/S1473-3099(13)70343-8 Vasan, 2011, In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers, PLoS ONE, 6, e19252, 10.1371/journal.pone.0019252 Casazza, 2013, Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire, J Infect Dis, 207, 1829, 10.1093/infdis/jit098 García, 2013, A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication, Sci Transl Med, 5, 166ra2, 10.1126/scitranslmed.3004682 Kalams, 2013, Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery, J Infect Dis, 208, 818, 10.1093/infdis/jit236 Bagarazzi, 2012, Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses, Sci Transl Med, 4, 155ra138, 10.1126/scitranslmed.3004414 Migueles, 2011, Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles, PLoS Pathog, 7, e1002002, 10.1371/journal.ppat.1002002 Varadarajan, 2011, A high-throughput single-cell analysis of human CD8+ T cell functions reveals discordance for cytokine secretion and cytolysis, J Clin Invest, 121, 4322, 10.1172/JCI58653 Wölfl, 2008, Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities, Cytometry A, 73, 1043, 10.1002/cyto.a.20594 Wolfl, 2007, Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities, Blood, 110, 201, 10.1182/blood-2006-11-056168 Migueles, 2002, HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nat Immunol, 3, 1061, 10.1038/ni845 Trabattoni, 2004, Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals, AIDS, 18, 859, 10.1097/00002030-200404090-00003 Berke, 1995, The CTL's kiss of death, Cell, 81, 9, 10.1016/0092-8674(95)90365-8 Malyguine, 2007, New approaches for monitoring CLT activity in clinical trials, Adv Exp Med Biol, 601, 273, 10.1007/978-0-387-72005-0_29 Trapani, 2002, Functional significance of the perforin/granzyme cell death pathway, Nat Rev Immunol, 2, 735, 10.1038/nri911 Pinkoski, 1998, Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis, Blood, 92, 1044, 10.1182/blood.V92.3.1044 Spaeny-Dekking, 1998, Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo, J Immunol, 160, 3610, 10.4049/jimmunol.160.7.3610 Vasan, 2011, In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers, PLoS ONE, 6, 19252, 10.1371/journal.pone.0019252 Shacklett, 2000, Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects, Virology, 10, 317, 10.1006/viro.2000.0299 Guadalupe, 2003, Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy, J Virol, 77, 11708, 10.1128/JVI.77.21.11708-11717.2003 Li, 2005, Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells, Nature, 434, 1148, 10.1038/nature03513 Poles, 2006, Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals, J Acquir Immune Defic Syndr, 43, 65, 10.1097/01.qai.0000230524.71717.14 Josefsson, 2013, The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time, Proc Natl Acad Sci USA, 110, E4987, 10.1073/pnas.1308313110 Belmonte, 2007, The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART, AIDS, 21, 2106, 10.1097/QAD.0b013e3282efb74b Morrow, 2009, Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity, Blood, 113, 5868, 10.1182/blood-2008-11-190520 Hirao, 2008, Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques, Vaccine, 26, 3112, 10.1016/j.vaccine.2008.02.036 Villarreal, 2014, Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity, Cancer Res, 15, 1789, 10.1158/0008-5472.CAN-13-2729 Palmer, 2011, HIV reservoirs and the possibility of a cure for HIV infection, J Intern Med, 270, 550, 10.1111/j.1365-2796.2011.02457.x Lafeuillade, 2011, Potential strategies for an HIV infection cure, HIV Clin Trials, 12, 121, 10.1310/hct1203-121 Shan, 2012, Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation, Immunity, 36, 491, 10.1016/j.immuni.2012.01.014